Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes.

Progress in cardiovascular diseases - 1 Jan 2000

Palazzuoli Alberto, Caravita Sergio, Paolillo Stefania, Ghio Stefano, Tocchetti Carlo Gabriele, Ruocco Gaetano, Correale Michele, Ambrosio Giuseppe, Perrone Filardi Pasquale, Senni Michele

Abstract excerpt

Heart Failure with preserved Ejection Fraction (HFpEF) is an increasingly prevalent clinical condition associated with cardiovascular aging, characterized by different pathophysiological mechanisms and poor outcomes. In this manuscript, we analysed the main differences in terms of updated diagnostic criteria and patients' selection in the most recent HFpEF trials. Recent algorithm purposed for HFpEF diagnosis,...

Topics

Join the communities discussing this publication.

Clinical Trials as Topic
Heart Failure
Patient Selection
Phenotype
Recovery of Function

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Treatment Outcome

Ventricular Function, Left

Source

Identifiers

PMID: 33839166
DOI: 10.1016/j.pcad.2021.03.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes.PMID 33839166Read ↗

Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.Semantic proximity Read ↗

Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach.Semantic proximity Read ↗

Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction.Semantic proximity Read ↗

Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.Semantic proximity Read ↗

The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratification.Semantic proximity Read ↗

Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies.Semantic proximity Read ↗

Towards a phenotype profiling of the patients with heart failure and preserved ejection fractionSemantic proximity Read ↗

Heart failure with preserved ejection fraction: A systemic disease linked to multiple comorbidities, targeting new therapeutic options.Semantic proximity Read ↗

Are HFpEF and HFmrEF So Different? The Need to Understand Distinct PhenotypesSemantic proximity Read ↗

Phenotypic spectrum of heart failure with preserved ejection fraction.Semantic proximity Read ↗

Insight into different phenotypic presentations of heart failure with preserved ejection fraction.Semantic proximity Read ↗

Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.